ILT Antibodies

Santa Cruz Biotechnology features a diverse variety of ILT Antibodies for the study of immune regulation and signaling pathways. ILT Antibodies are compatible with multiple research techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ILT (Immunoglobulin-like Transcript) proteins play a crucial role in modulating immune responses, particularly in immune tolerance and the regulation of dendritic cell function. Understanding ILT protein function is essential for elucidating their involvement in autoimmune diseases and cancer immunology. Research focused on ILT proteins can provide insights into therapeutic targets for enhancing immune responses or restoring tolerance. Investigating ILT proteins has revealed significant implications for developing targeted immunotherapies. Ongoing research continues to uncover new functions and regulatory mechanisms of ILT proteins in immune system homeostasis. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing immune regulation studies and developing innovative therapeutic strategies.